Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix

Detalles Bibliográficos
Autores principales: Mann, Minakshi, Kumar, Sachin, Chauhan, Shyam S., Bhatla, Neerja, Kumar, Sunesh, Bakhshi, Sameer, Gupta, Ritu, Sharma, Ashok, Kumar, Lalit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677665/
https://www.ncbi.nlm.nih.gov/pubmed/31413820
http://dx.doi.org/10.18632/oncotarget.27101
_version_ 1783440929704640512
author Mann, Minakshi
Kumar, Sachin
Chauhan, Shyam S.
Bhatla, Neerja
Kumar, Sunesh
Bakhshi, Sameer
Gupta, Ritu
Sharma, Ashok
Kumar, Lalit
author_facet Mann, Minakshi
Kumar, Sachin
Chauhan, Shyam S.
Bhatla, Neerja
Kumar, Sunesh
Bakhshi, Sameer
Gupta, Ritu
Sharma, Ashok
Kumar, Lalit
author_sort Mann, Minakshi
collection PubMed
description
format Online
Article
Text
id pubmed-6677665
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-66776652019-08-14 Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix Mann, Minakshi Kumar, Sachin Chauhan, Shyam S. Bhatla, Neerja Kumar, Sunesh Bakhshi, Sameer Gupta, Ritu Sharma, Ashok Kumar, Lalit Oncotarget Correction Impact Journals LLC 2019-07-30 /pmc/articles/PMC6677665/ /pubmed/31413820 http://dx.doi.org/10.18632/oncotarget.27101 Text en Copyright: © 2019 Mann et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Mann, Minakshi
Kumar, Sachin
Chauhan, Shyam S.
Bhatla, Neerja
Kumar, Sunesh
Bakhshi, Sameer
Gupta, Ritu
Sharma, Ashok
Kumar, Lalit
Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
title Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
title_full Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
title_fullStr Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
title_full_unstemmed Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
title_short Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
title_sort correction: parp-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677665/
https://www.ncbi.nlm.nih.gov/pubmed/31413820
http://dx.doi.org/10.18632/oncotarget.27101
work_keys_str_mv AT mannminakshi correctionparp1inhibitormodulatebcateninsignalingtoenhancecisplatinsensitivityincancercervix
AT kumarsachin correctionparp1inhibitormodulatebcateninsignalingtoenhancecisplatinsensitivityincancercervix
AT chauhanshyams correctionparp1inhibitormodulatebcateninsignalingtoenhancecisplatinsensitivityincancercervix
AT bhatlaneerja correctionparp1inhibitormodulatebcateninsignalingtoenhancecisplatinsensitivityincancercervix
AT kumarsunesh correctionparp1inhibitormodulatebcateninsignalingtoenhancecisplatinsensitivityincancercervix
AT bakhshisameer correctionparp1inhibitormodulatebcateninsignalingtoenhancecisplatinsensitivityincancercervix
AT guptaritu correctionparp1inhibitormodulatebcateninsignalingtoenhancecisplatinsensitivityincancercervix
AT sharmaashok correctionparp1inhibitormodulatebcateninsignalingtoenhancecisplatinsensitivityincancercervix
AT kumarlalit correctionparp1inhibitormodulatebcateninsignalingtoenhancecisplatinsensitivityincancercervix

Ejemplares similares